Treatment and prognosis of primary focal segmental glomerulosclerosis

Contributions to Nephrology

Volumn 181, Issue , 2013, Pages 109-118

  Ren, Hong ^a   Shen, Pingyan ^a   Li, Xiao ^a   Pan, Xiaoxia ^a   Zhang, Qianying ^a   Feng, Xiaobei ^a   Zhang, Wen ^a   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SURVIVAL RATE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84958643856     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000348468     Document Type: Review

References (17)

1. Kitiyakara C, Eggers P, Kopp JB: Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 2004; 44:815-825. (Pubitemid 39445913)
2. Korbet SM: Primary focal segmental glomer-ulosclerosis; in Brady HR, Wilcox CS (eds): Therapy in Nephrology and Hypertension. A Companion to Brenner and Rector's The kidney. Philadelphia, Saunders, 1999, pp 178-188.
3. Gipson DS, Chin H, Presler TP, et al: Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol 2006; 21:344-349. (Pubitemid 43280349)
4. Singh A, Tejani C, Tejani A: One-center experience with cyclosporine in refractory ne-phrotic syndrome in children. Pediatr Nephrol 1999; 13:26-32. (Pubitemid 29206254)
5. Troyanov S, Wall CA, Miller JA, et al: Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol 2005; 16:1061-1068. (Pubitemid 41710316)
6. Rydel JJ, Korbet SM, Borok RZ, et al: Focal segmental glomerulosclerosis in adults: presentation, course and response to treatment. Am J Kidney Dis 1995; 25:534-542.
7. Pan B, Jang Z, Chang J, et al: Clinicopatho-logical analysis of adult primary focal segmental glomerulosclerosis in 263 cases. Chin J Nephrol 2007; 23:13-17.
8. Prayaga AK, Anuradha SV, Manjusha Y, et al: Morphologic evaluation of renal function using semiquantitative method in primary nonproliferative glomerular diseases. Indian J Pathol Microbiol 2011; 54:42-46.
9. Barisoni L, Valeri A, D'Agati V, et al: FSGS: A 20-year epidemiologic study. J Am Soc Nephrol 1994; 5:347.
10. Deegens JK, Steenbergen JE, Borm GF, et al: Pathologic variants of focal segmental glo-merulosclerosis in an adult Dutch population-epidemiology and outcome. Nephrol Dial Transplant 2008; 23:186-192. (Pubitemid 351767360)
11. Chun MJ, Korbet SM, Schwartz MM, et al: Focal segmental glomerulosclerosis in ne-phrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 2004; 15:2169-2177. (Pubitemid 39031355)
12. Tang Xi, Liu Zhi-Hong, Xu Feng: Long-term outcome of adult patients with idiopathic focal segmental glomerulosclerosis Chin J Nephrol Dial Transplant 2010; 19:23-29.
13. Korbet SM: Treatment of primary FSGS in adults. J Am Soc Nephrol 2012; 23:1769-1776.
14. Ren H, Shen P, Li X, et al: Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulo-sclerosis: a randomized controlled trial. Am J Nephrol 2013; 37:84-90.
15. Korbet SM: Angiotensin antagonists and steroids in treatment of focal segmental glomer-ulosclerosis. Semin Nephrol 2003; 23:219-228. (Pubitemid 36397104)
16. Meyrier A: An update on the treatment options for focal segmental glomerulosclerosis. Expert Opin Pharmacother 2009; 10:615-628.
17. Crook ED, Habeeb D, Gowdy O, et al: Effects of steroids on focal segmental glomer-ulosclerosis in a predominantly African-American population. Am J Med Sci 2005; 330: 19-24. (Pubitemid 41003682)